Common Diabetes Drug Effective Against Knee Arthritis Pain

A common diabetes drug can be repurposed to help overweight and obese people with knee arthritis, a new study says.

Metformin reduced knee arthritis pain during a six-month treatment period, potentially delaying the need for knee replacement surgery, researchers reported recently in the Journal of the American Medical Association....

Middle-Age Exercise Protects Brain Against Alzheimer's

FRIDAY, May 2, 2025 (HealthDay News) — Want to protect your aging brain? Get off the couch and get moving, researchers urge.

Boosting exercise in middle age might help people prevent Alzheimer’s disease, a new study says.

People who increased their physical activity to meet recommended guidelines between ages 45 and 65 ha...

Mindfulness Meditation Counters Opioid Cravings

Mindfulness meditation can help rewire the brain to reduce opioid cravings in people addicted to narcotics, a new study says.

People assigned to mindfulness training had 50% less opioid cravings than others who received supportive group therapy, researchers reported April 30 in JAMA Psychiatry.

“Opioid addiction decrea...

Your Loving Partner Can Protect You From Chemo Brain

FRIDAY, May 2, 2025 (HealthDay News) — A cancer patient’s bond with their partner can be a key factor in helping them ward off chemotherapy-related “brain fog,” a new study says

Patients in a satisfying intimate relationship were more likely to resist chemo brain, the cognitive impairment that can occur during or af...

Scooter Riders Were High Or Drunk In A Quarter Of Wrecks

Don’t drink and drive is a message the public has largely accepted.

Now how about don’t drink and scoot?

A quarter of people injured in electric scooter accidents were drunk or high when their mishap occurred, researchers recently reported in the journal The American Surgeon.

“In today’s landsca...

FDA Commissioner: No Major Reorganization, Just Smart Reforms

THURSDAY, May 1, 2025 (HealthDay News) — Dr. Marty Makary had just finished his last surgery at Johns Hopkins when he stepped into one of the most powerful roles in American public health. 

Now, as the new commissioner of the U.S. Food and Drug Administration (FDA), he's wasting no time charting a new course for the agency.